Cargando…
S2 Subunit of SARS-nCoV-2 Interacts with Tumor Suppressor Protein p53 and BRCA: an In Silico Study
Novel coronavirus disease 2019 (COVID-19) is the biggest threat to human being globally. The first case was identified in a patient with flu symptoms along with severe acute respiratory syndrome in Wuhan, China in December 2019 and now it has spread in more than 200 countries. COVID-19 is more letha...
Autores principales: | Singh, Nishant, Bharara Singh, Anuradha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324311/ https://www.ncbi.nlm.nih.gov/pubmed/32619819 http://dx.doi.org/10.1016/j.tranon.2020.100814 |
Ejemplares similares
-
Novel Coronavirus (nCoV): a Bitter Old Enemy in a New Avatar
por: Singh, Anuradha Bharara, et al.
Publicado: (2020) -
Deubiquitinases and cancer: A snapshot
por: Singh, Nishant, et al.
Publicado: (2016) -
ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
por: Chauhan, Anil, et al.
Publicado: (2020) -
In Silico Evaluation of Binding of 2-Deoxy-D-Glucose with Mpro of nCoV to Combat COVID-19
por: Raman, Anirudh Pratap Singh, et al.
Publicado: (2022) -
Reply: Subacute thyroiditis after anti-SARS-CoV-2 (Ad5-nCoV) vaccine()
por: Flores-Rebollar, Armando
Publicado: (2022)